Page 40 - 南京医科大学学报自然科学版
P. 40

南京医科大学学报(自然科学版)                                 第43卷第10期
               ·1366 ·                    Journal of Nanjing Medical University(Natural Sciences)  2023年10月


             ·基础研究·

              利用CRISPER/Cas9技术构建肝脏特异性敲入Lcat基因小鼠



              张芙蓉 ,苟黎明 ,李 妍 ,王泽勇 ,杨 斐 ,吴                   菁 ,覃 健 ,薛 斌        1*
                                             3
                                     2
                     1
                             1
                                                     3
                                                             1
                                                                     3*
               南京医科大学附属逸夫医院中心实验室,检验科,骨科,江苏 南京                        211166
              1                               2      3
             [摘    要] 目的:通过 CRISPR/Cas9 介导的基因编辑技术构建卵磷脂胆固醇脂酰转移酶(lecithin⁃cholesterol acyltransferase,
              LCAT)基因敲入C57BL/6小鼠并与肝脏特异性表达Cre 的转基因小鼠配繁得到肝脏特异性敲入Lcat 基因C57BL/6小鼠模型。
              为Lcat基因在肝脏相关代谢疾病发生机制的研究提供动物模型。方法:利用CRISPR/Cas9技术构建Lcat基因敲入小鼠;利用
              肝脏特异性表达Cre的转基因小鼠与Lcat基因敲入小鼠交配得到肝脏特异性敲入Lcat基因小鼠;通过PCR法鉴定小鼠的基因
              型 ;利用实时荧光定量 PCR(real⁃time quantitative PCR,qPCR)和 Western blot 技术验证 Lcat 基因的 mRNA 水平和蛋白水平。
              结果:PCR 结果显示肝脏特异性敲入 Lcat 基因的小鼠模型构建成功;qPCR 结果显示 Lcat 基因在肝脏中特异性高表达;WB结
              果显示,与对照组小鼠相比,LCAT蛋白在肝脏特异性敲入Lcat的小鼠肝脏中有明显更高的表达。结论:成功构建肝脏特异性
              敲入Lcat基因小鼠,为在动物水平探索Lcat基因在肝脏相关代谢疾病中的功能及相关发病机制提供研究平台。
             [关键词] CRISPR/Cas9;Lcat;肝脏特异性;基因敲入
             [中图分类号] Q785                     [文献标志码] A                       [文章编号] 1007⁃4368(2023)10⁃1366⁃06
              doi:10.7655/NYDXBNS20231005


              Establishment of liver⁃specific Lcat knock⁃in mouse models by the CRISPER/Cas9 technique

                                                                                         3*
                                               2
                                                             3
                                       1
                           1
                                                                                1
                                                                       3
              ZHANG Furong ,GOU Liming ,LI Yan ,WANG Zeyong ,YANG Fei ,WU Jing ,QIN Jian ,XUE Bin  1*
               Department of Central Laboratory,Department of Clinical Laboratory,Department of Orthopedics,Sir Run Run
              1                             2                              3
              Hospital,Nanjing Medical University,Nanjing 211166,China
             [Abstract] Objective:To construct lecithin⁃cholesterolacyl transferase(LCAT)knock⁃in mice by CRISPR/Cas9⁃mediated gene
              editing and to obtain liver⁃specific overexpression of Lcat mice by mating with liver⁃specific Cre⁃expressing transgenic mice. Providing
              an animal model for the study of the mechanism of the Lcat gene in the development of liver⁃related metabolic diseases. Methods:Lcat
              knock⁃in mice were constructed by CRISPR/Cas9 technology;Liver⁃specific Cre⁃expressing transgenic mice were mated with Lcat
              knock⁃in mice to obtain liver⁃specific overexpressing Lcat mice;Genotyping mice by PCR;Quantitative real⁃time PCR(qPCR)and
              Western blot(WB)techniques were used to verify the expression of Lcat gene in C57BL/6 mice. Results:The PCR results showed that
              the liver⁃specific overexpression of Lcat gene in mice was successfully constructed;the qPCR results showed that the Lcat gene was
              specifically highly expressed in the liver,and the liver of knock⁃in mice showed higher Lcat expression;the WB results showed that
              LCAT protein was more highly expressed in the liver of liver⁃specific Lcat knock⁃in mice. Conclusion:Liver⁃specific overexpression of
              Lcat gene mice were successfully constructed,providing a platform for exploring the function of the Lcat gene at animal level in liver⁃related
              metabolic diseases and the associated pathogenesis.
             [Key words] CRISPR/Cas9;Lcat;liver⁃specific;gene knock⁃in
                                                                           [J Nanjing Med Univ,2023,43(10):1366⁃1371]









             [基金项目] 国家自然科学基金(32271187,32071142);江苏省青蓝工程(KY520R202025);省部共建协同创新中心
             (JZ21449020210617);南京市卫生科技发展专项资金项目(YKK21256)
              ∗
              通信作者(Corresponding author),E⁃mail:qinjian@njmu.edu.cn;xuebin@njmu.edu.cn
   35   36   37   38   39   40   41   42   43   44   45